Marc Flajolet
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2024First federal award
$2.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 17, 2026 | NIH | SBIR Phase II Advancing DEL-derived Small Molecule Inhibitors of Pathological Tau Toward Preclinical Development for Alzheimer’s Disease and Tauopathies | $1.1M | JILLION THERAPEUTICS INC. |
| Jun 20, 2025 | NIH | SBIR Phase I Identification of therapeutic molecules to treat amphetamine use disorders using our DNA-encoded library (DEL) technology | $398K | JILLION THERAPEUTICS INC. |
| May 7, 2025 | NIH | SBIR Phase I Synergy between Artificial Intelligence and DNA-Encoded Library technologies to Identify Polypharmacological Therapeutics for Substance Use Disorders | $399K | JILLION THERAPEUTICS INC. |
| Aug 28, 2024 | NIH | SBIR Phase I The use of DNA-encoded library (DEL) technology for the identification of therapeutic molecules to treat opioid use disorders (OUDs) | $400K | JILLION THERAPEUTICS INC. |
| Aug 23, 2024 | NIH | SBIR Phase I Targeting biologically relevant tau monomers and oligomers using a novel DEL drug discovery platform to treat Alzheimer’s disease and tauopathies | $496K | JILLION THERAPEUTICS INC. |
Peer ranks
Federal funding#675
Awards as PI#417
Patents#273
Companies
- JILLION THERAPEUTICS INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.